Ovid Therapeutics Inc (OVID) — Capital Reinvestment Ratio
Ovid Therapeutics Inc (OVID) has a Capital Reinvestment Ratio of 0.00x as of March 2021, meaning it reinvests 0% of its operating cash flow ($160.90 Million) in capital expenditures ($11.51K). Check tangible equity quality of Ovid Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ovid Therapeutics Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Ovid Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Ovid Therapeutics Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Ovid Therapeutics Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Ovid Therapeutics Inc from 2021 to 2021. See OVID free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $118.61 Million | $189.41K | — |